Kiss-1抑制宫颈癌细胞增殖和侵袭的作用机制
Mechanism of Kiss-1 Inhibiting Proliferation and Invasion of Cervical Cancer Cells
DOI: 10.12677/ACM.2022.125664, PDF,    科研立项经费支持
作者: 宋欧诣, 王 丽, 江 速, 周金红, 杨步琴:广东省深圳市宝安区人民医院,广东 深圳
关键词: Kiss-1基因宫颈癌侵袭转移Kiss-1 Cervical Cancer Invasion Migration
摘要: 目的:研究kiss-1基因在宫颈癌SiHa细胞增殖活力和侵袭迁徙能力中发挥的作用机制,以便为宫颈癌的治疗提供新的靶点。方法:选取kiss-1基因过表达后稳定转染SiHa宫颈癌细胞。本实验分为3组。1) 空白组为常规宫颈癌SiHa细胞;2) 空载体组为转染空载体的宫颈癌SiHa细胞;3) 过表达组为转染稳定kiss-1基因的宫颈癌SiHa细胞。Western blot法分析3组kiss-1基因蛋白的表达量差异,CCK-8测出3组细胞增殖活力,Transwell模型测3组细胞侵袭能力和转移能力。结果:过表达组kiss-1基因蛋白表达量最高,过表达组中Ecadherin的表达是明显上调(P < 0.05),相反Vimentin的表达明显下调(P < 0.05)。转染kiss-1基因的过表达组细胞增殖活力明显低于其他两组(P < 0.05),尤其在12小时的穿膜细胞个数计数方面,转染kiss-1基因过表达组的个数显著高于其他两组(P < 0.05)。转染kiss-1基因的过表达组可明显的抑制宫颈癌SiHa细胞的侵袭能力和转移能力。结论:kiss-1基因过表达能显著抑制宫颈癌疾病侵袭转移。
Abstract: Objective: To study the mechanism of Kiss-1 in the proliferation and invasion of cervical cancer SiHa cell, and analyze the relative mechanism to supply effective therapy targets to cervical cancer. Methods: Kiss-1 over expression plasmid was transfected into cervical cancer cell lines of SiHa. There were three groups. 1) SiHa control; 2) Treated with empty vector; 3) Treated with kiss-1 gene vector. Western blot analysis of three groups kiss-1 gene protein expression, cell proliferation via-bility was measured by CCK-8, and cell invasion ability and metastasis ability in the transwell model. Results: After transfection of pEGFPC1/Kiss-1 into cervical cancer cell lines of SiHa (over-express group), the protein of kiss-1 was highest, the expression of E-cadherin was significantly higher (P < 0.05); however, the expression of Vimentin was significantly lower than other groups (P < 0.05). Migration ability of the cells in over-expression group was decreased than SiHa control (P < 0.05). The migrating cells were obviously decreased than SiHa control at 12 h after transfection of pEGFPC1/Kiss-1 into SiHa cells (P < 0.05). Over-express group of Kiss-1 could decrease the invasion ability and metastasis ability of cervical cancer SiHa. Conclusion: Over-express of Kiss-1 gene could decrease the potential of invasion and metastasis of cervical cancer.
文章引用:宋欧诣, 王丽, 江速, 周金红, 杨步琴. Kiss-1抑制宫颈癌细胞增殖和侵袭的作用机制[J]. 临床医学进展, 2022, 12(5): 4599-4605. https://doi.org/10.12677/ACM.2022.125664

参考文献

[1] Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
[2] Dyer, B.A., Zamarin, D., Eskandar, R.N. and Mayadev, J.M. (2019) Role of Immunotherapy in the Management of Locally Advanced and Recurrent/Metastatic Cervical Cancer. Journal of the National Comprehensive Cancer Network: JNCCN, 17, 91-97. [Google Scholar] [CrossRef] [PubMed]
[3] Park, K.J., Braschi-Amirfarzan, M., DiPiro, P.J., et al. (2016) Mul-timodality Imaging of Locally Recurrent and Metastatic Cervical Cancer: Emphasis on Histology, Prognosis, and Man-agement. Abdominal Radiology (New York), 41, 2496-2508. [Google Scholar] [CrossRef] [PubMed]
[4] 乔友林. 中国宫颈癌防治任重而道远[J]. 中华肿瘤杂志, 2018, 40(10): 721-723.
[5] 陈春林, 黎志强. 加强子宫颈癌患者诊治的全程管理[J]. 中国实用妇科与产科杂志, 2021, 37(1): 18-24.
[6] Lee, J.H., Miele, M.E., Hicks, D.J., et al. (1996) KiSS-1, a Novel Human Malignant Melanoma Metastasis-Suppressor Gene. Journal of the National Cancer Institute, 88, 1731-1737. [Google Scholar] [CrossRef] [PubMed]
[7] Lee, J.H. and Welch, D. (1997) Suppression of Metastasis in Human Breast Carcinoma MDA-MB-435 Cells after Transfection with the Metastasis Suppressor Gene, Kiss-1. Cancer Research, 57, 2384-2387.
[8] 姜海斌, 王景广, 杨明, 韩双双, 刘德华, 于卫芳. Kiss-1、Kiss-1R蛋白在胃腺癌中的表达及临床意义[J]. 河北医科大学学报, 2018(5): 514-518.
[9] 胡潇滨. Kiss-1基因抑制胃癌脏器转移的机制研究[D]: [硕士学位论文]. 沈阳: 中国医科大学, 2018.
[10] 徐唯嘉, 王家宏. KISS-1基因相关研究进展[J]. 系统医学, 2019(1): 192-195.
[11] 李颖, 王瑚. KiSS1蛋白和MMP-2在宫颈癌组织中的表达及诊断价值[J]. 中国实验诊断学, 2018(3): 460-461.
[12] Cao, R.L., Shao, J.L., Hu, Y.B., et al. (2021) Correction to: Mi-croRNA-338-3p Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma Cells by Targeting Activator of 90 kDa Heat Shock Protein ATPase Homolog. Cancer Cell International, 21, 560. [Google Scholar] [CrossRef] [PubMed]
[13] Saitoh, M. (2018) Involvement of Partial EMT in Cancer Pro-gression. Journal of Biochemistry, 164, 257-264. [Google Scholar] [CrossRef] [PubMed]
[14] Suarez-Carmona, M., Lesage, J., Cataldo, D. and Gilles, C. (2017) EMT and Inflammation: Inseparable Actors of Cancer Progression. Molecular Oncology, 11, 805-823. [Google Scholar] [CrossRef] [PubMed]
[15] Pastushenko, I. and Blanpain, C. (2019) EMT Transition States during Tumor Progression and Metastasis. Trends in Cell Biology, 29, 212-226. [Google Scholar] [CrossRef] [PubMed]
[16] Huo, X., Zhang, L. and Li, T. (2018) Analysis of the Association of the Expression of KiSS-1 in Colorectal Cancer Tissues with the Pathology and Prognosis. Oncology Letters, 15, 3056-3060. [Google Scholar] [CrossRef] [PubMed]
[17] Song, W.W., Gui, A.P., Li, W., Chen, H. and Li, J.M. (2017) Expressions of HIF-1α and KISS-1 in Patients with Liver Cancer and Correlation Analysis. European Review for Medi-cal and Pharmacological Sciences, 21, 4058-4063.
[18] Shin, W.J., Cho, Y.A., Kang, K.R., Kim, J.H., Hong, S.D., Lee, J.I., Hong, S.P. and Yoon, H.J. (2016) KiSS-1 Expression in Oral Squamous Cell Carcinoma and Its Prognostic Signif-icance. APMIS, 124, 291-298. [Google Scholar] [CrossRef] [PubMed]
[19] Fratangelo, F., Carriero, M.V. and Motti, M.L. (2018) Controversial Role of Kisspeptins/KiSS-1R Signaling System in Tumor Development. Frontiers in Endocrinology (Lausanne), 9, Article No. 192. [Google Scholar] [CrossRef] [PubMed]